We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$3.85B
1-Year Est. Return
32.11%
This Fund
S&P 500
This Quarter
Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
(-8.5%)
Cap. Flow
-$110M
Cap. Flow
% of AUM
-11.98%
Top 10 Holdings %
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$11.2M |
| 2 |
ExxonMobil
XOM
|
+$10.8M |
| 3 |
Apple
AAPL
|
+$10.8M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$10.2M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$8.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$265M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$98.3M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$32.7M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$18.2M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$14.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 8.29% |
| 3 | Industrials | 7.33% |
| 4 | Healthcare | 6.94% |
| 5 | Consumer Discretionary | 6.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Credit Acceptance
CACC
$6.08B
| $17K | ﹤0.01% |
+79
| New | +$15.3K |
|
2277
Avis
CAR
$5.02B
| $17K | ﹤0.01% |
461
-1,765
| -79% | -$63.9K |
|
2278
Calamos Strategic Total Return Fund
CSQ
$3.35B
| $17K | ﹤0.01% |
+1,674
| New | +$16.9K |
|
2279
Duluth Holdings
DLTH
$159M
| $17K | ﹤0.01% |
+639
| New | +$18.5K |
|
2280
Vaalco Energy
EGY
$594M
| $17K | ﹤0.01% |
+15,629
| New | +$13.8K |
|
2281
FRP Holdings
FRPH
$421M
| $17K | ﹤0.01% |
892
+92
| +12% | +$1.63K |
|
|
STRR
2282
Star Equity Holdings
STRR
$41.7M
| $17K | ﹤0.01% |
1,272
+1,032
| +430% | +$15.3K |
|
2283
Insmed
INSM
$28.6B
| $17K | ﹤0.01% |
+1,271
| New | +$17.3K |
|
2284
Jones Lang LaSalle
JLL
$16.7B
| $17K | ﹤0.01% |
164
-1,162
| -88% | -$117K |
|
2285
MillerKnoll
MLKN
$1.67B
| $17K | ﹤0.01% |
508
-1,007
| -66% | -$31.4K |
|
2286
MYR Group
MYRG
$5.25B
| $17K | ﹤0.01% |
453
-1,772
| -80% | -$60.9K |
|
2287
Noodles & Co
NDLS
$107M
| $17K | ﹤0.01% |
528
+492
| +1,367% | +$17.6K |
|
2288
Northrim BanCorp
NRIM
$587M
| $17K | ﹤0.01% |
+2,248
| New | +$15.6K |
|
|
OPP
2289
RiverNorth/DoubleLine Strategic Opportunity Fund
OPP
$191M
| $17K | ﹤0.01% |
+911
| New | +$17.5K |
|
2290
Sprott Physical Gold
PHYS
$15.7B
| $17K | ﹤0.01% |
1,800
+500
| +38% | +$5.01K |
|
2291
Q2 Holdings
QTWO
$3.92B
| $17K | ﹤0.01% |
+598
| New | +$17.7K |
|
2292
Surgery Partners
SGRY
$2.03B
| $17K | ﹤0.01% |
+1,063
| New | +$17.7K |
|
2293
Thor Industries
THO
$4.14B
| $17K | ﹤0.01% |
170
-6,043
| -97% | -$545K |
|
2294
Turkcell
TKC
$4.79B
| $17K | ﹤0.01% |
+2,537
| New | +$18.5K |
|
|
X
2295
DELISTED
US Steel
X
| $17K | ﹤0.01% |
529
-6,534
| -93% | -$175K |
|
|
PSIX
2296
Power Solutions International
PSIX
$942M
| $17K | ﹤0.01% |
2,299
+450
| +24% | +$4.93K |
|
|
XYZ
2297
Block Inc
XYZ
$47.5B
| $17K | ﹤0.01% |
+1,236
| New | +$15.4K |
|
|
FIEE
2298
DELISTED
FI Enhanced Europe 50 ETN
FIEE
| $17K | ﹤0.01% |
+144
| New | +$16.2K |
|
|
MGI
2299
DELISTED
MoneyGram International, Inc. New
MGI
| $17K | ﹤0.01% |
+1,438
| New | +$13.4K |
|
|
TA
2300
DELISTED
TravelCenters of America LLC
TA
| $17K | ﹤0.01% |
+481
| New | +$16.3K |
|
Similar funds
HFCIX
DWM
TFM
AC
IP
TCIM
FLSM
AFI
Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review
As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.
Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.
- Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
- Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
- Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
- Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
- Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
- Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
- Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.